National nonprofit watchdog organization Public Citizen has released its findings of a study of 25 years of data, which highlight the $35.7 billion in settlements agreed upon by pharmaceutical companies and federal and state governments. During the period from 1991 through 2015, pharmaceutical giants agreed... Read More

A number of Zofran lawsuits have been filed against GlaxoSmithKline (GSK) with regard to the drug's side effects on unborn children. One of the most recent cases filed against GSK alleges that the defendant’s wrongful conduct and fraudulent misrepresentation directly resulted in a minor child’s severe heart defects... Read More

A Tennessee resident took legal action against the pharmaceutical company GlaxoSmithKline LLC (GSK) in December of 2015 on behalf of her minor child. The plaintiff alleged that her baby developed a serious birth defect after she took Zofran—also known as odansetron—during her pregnancy to alleviate... Read More

Last month, GlaxoSmithKline LLC asked the federal district court overseeing the Zofran birth defects multidistrict litigation (MDL) to dismiss the complaints or grant judgment in favor of the drug manufacturer on all of the involved lawsuits. The motion, filed on December 11, 2015, in the... Read More

On December 30, 2015, a mother from California filed a lawsuit against the pharmaceutical company GlaxoSmithKline LLC (GSK), claiming that the defendant's anti-emetic medication Zofran resulted in a congenital heart defect in her child following his birth in 2009. She is demanding compensation in excess... Read More

In a recently filed lawsuit, a Texas woman claims that congenital defects she has lived with since birth are the result of her mother's use of anti-nausea medication Zofran (ondansetron) during pregnancy. Alleging negligence, fraud, misrepresentation and breaches of express and implied warranties on the... Read More

On October 30, 2015, a family from Alabama filed a Zofran lawsuit against GlaxoSmithKline (GSK), claiming that the defendants’ medication resulted in their child’s birth defects. They demand compensation in excess of $75,000 for past and future medical expenses, as well as other damages. The... Read More

A plaintiff has filed a lawsuit in Louisiana, alleging use of Zofran during pregnancy led to birth defects in her newborn son. The complaint joins dozens of others filed against Zofran manufacturer GlaxoSmithKline, most of which are now coordinated in multidistrict litigation in U.S. District... Read More